N/A
N=555
Randomized Controlled Trial of Wellness Recovery Action Planning
Mental Disorders
Bottom Line
View on ClinicalTrials.gov: NCT01024569 ↗Enrolled (actual)
555
Serious AEs
0.0%
Results posted
Jan 2020
Primary outcome: Primary: Psychiatric Symptoms Recovery Using the Brief Symptoms Inventory (BSI) — 20.6; 19.29; 19.52; 21.38 symptom severity score — p=0.027
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Wellness Recovery Action Planning (WRAP) (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Illinois at Chicago
- Primary completion
- Sep 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Psychiatric Symptoms Recovery Using the Brief Symptoms Inventory (BSI) |
20.6; 19.29; 19.52; 21.38; 12.20; 12.65 | 0.027 sig |
| PRIMARY Hopefulness |
21.67; 21.87; 22.47; 22.07; 22.76; 22.16 | 0.020 sig |
| PRIMARY Patient Self-Advocacy |
3.47; 3.46; 3.61; 3.53; 3.65; 3.55 | 0.029 sig |
| PRIMARY Recovery From Mental Illness |
88.2; 87.4; 92.9; 90.0; 93.7; 91.2 | 0.042 sig |
| SECONDARY Quality of Life Brief Assessment |
13.1; 13.1; 13.7; 13.5; 14.1; 13.4 | .001 sig |
Summary
The purpose of this research study is to test the effectiveness of a standardized peer-led intervention to teach self-management skills in improving outcomes of individuals with a severe mental illness. The intervention is known as Wellness Recovery Action Planning or WRAP, co-developed by Dr. Mary Ellen Copeland. The focus of the inquiry is on whether and how developing an individualized plan for successful living: 1) lowers psychiatric symptoms; 2) enhances psychosocial outcomes such as self-perceived recovery, empowerment, self-advocacy, coping, and social support; 3) increases knowledge of personal mental illness self-management strategies; and 4) enhances satisfaction with the service delivery system. The study evaluated the following hypotheses:
Hypothesis #1: Compared to wait-list control subjects, those who participate in the WRAP intervention will report reduced levels of psychiatric symptoms.
Hypothesis #2: Compared to wait-list control subjects, those who participate in the WRAP intervention will report enhanced enhanced feelings of empowerment, hope, recovery, quality of life, and functioning.
Hypothesis #3: Compared to wait-list controls, those who participate in the WRAP intervention will report increased levels of social support.
Hypothesis #4: Compared to wait-list controls, those who participate in the WRAP intervention will report increased use of peer services, higher satisfaction with services, and have lower overall service costs.
Hypothesis #5: Compared to controls, those who participate in the WRAP intervention will report increased knowledge of mental illness self-management, including making/using a WRAP plan.
Hypothesis #6: There will be no difference in employment rates of control vs. intervention subjects.
Eligibility Criteria
Inclusion Criteria
- age 18 years or older
- English speaking
- severe mental illness as confirmed by: 1) a Kessler Self-Report Measure (K-6) score of 13 or higher; and/or 2) enrolled as a client of the public mental health system in the state of Ohio.
Exclusion Criteria
- non English speaking
- not meeting clinical criteria for severe mental illness
Data sourced from ClinicalTrials.gov (NCT01024569). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.